Molecular Insights for Harnessing Urine Biomarkers in Precision Medicine
- 1st Edition - April 1, 2027
- Latest edition
- Editors: Cheng Xue, Jing Xu, Bo Yang, Lyu Jiayi, Lujiang Yi
- Language: English
Molecular Insights for Harnessing Urine Biomarkers in Precision Medicine provides a comprehensive exploration into the molecular signatures and clinical implications of urine… Read more
Description
Description
From historical perspectives to cutting-edge technologies, this reference presents an updated understanding of urine biomarkers' role across diverse bodily systems. With sections devoted to fundamental concepts, molecular signatures, and clinical applications, readers gain a deep understanding of urine biomarkers' significance in disease diagnosis and personalized medicine. Each chapter explores specific body systems, including renal, urological, cardiovascular, and respiratory, uncovering the diagnostic potential of urine biomarkers in various conditions like cancer, cardiovascular diseases, and neurological disorders. Highlighted are the latest advances in technology, challenges, and future directions, keeping readers abreast of the rapidly evolving landscape of urine biomarker research. Real-world case studies illustrate practical applications, enhancing comprehension and facilitating knowledge transfer to clinical practice.
Key features
Key features
- Explores the latest advancements in molecular signatures, providing insights on how urine biomarkers outshine traditional diagnostics and offers unprecedented insights into diseases affecting multiple bodily systems
- Uncovers real-world applications of urine biomarkers through engaging case studies, thus demonstrating their effectiveness in clinical settings
- Navigates the future of healthcare diagnostics by exploring emerging trends and technological frontiers in urine biomarker research
- Includes a focus on personalized medicine and integration with other diagnostic modalities
Readership
Readership
Table of contents
Table of contents
1. Background and Significance and Historical Perspective of Urine Biomarkers in Medicine
2. Rationale for Exploring Urine Biomarkers
Section II. Fundamentals of Urine Biomarkers
3. Definition and Types of Biomarkers
4. Characteristics of Ideal Urine Biomarkers
Section III. Molecular Signatures in Urine
5. Cellular Components in Urine
6. Genetic and Epigenetic Markers
7. Proteomic and Metabolomic Signatures
8. MicroRNA and Non-Coding RNA Profiles
Section IV. Urine Biomarkers Across Body Systems
9. Renal System
10. Urological System
11. Cardiovascular System
12. Endocrine System
13. Musculoskeletal System
14. Immune System
15. Respiratory System
16. Blood system
17. Digestive system
18. J. Nervous system
Section V. Techniques for Urine Biomarker Detection
19. Laboratory Techniques
20. Point-of-Care Testing
Section VI. Clinical Implications and Applications
21. Diagnosis and Prognosis
22. Monitoring Disease Progression
23. Treatment Response Assessment
24. Personalized Medicine Approaches
Section VII. Challenges and Limitations
25. Standardization Issues
26. Variability in Urine Composition
27. Ethical Considerations
28. Cost-effectiveness
Section VIII. Future Directions and Emerging Trends
29. Advances in Technology
30. Integration with Other Diagnostic Modalities
31. Potential Therapeutic Targets
Section IX. Case Studies
32. Real-world Applications of Urine Biomarkers
33. Success Stories and Lessons Learned
Section X. Conclusion
34. Implications for Future Research and Clinical Practice
35. Summary of Key Findings
Product details
Product details
- Edition: 1
- Latest edition
- Published: April 1, 2027
- Language: English
About the editors
About the editors
CX
Cheng Xue
Cheng Xue is Deputy Chief Physician and Professor in the Department of Nephrology at Shanghai Changzheng Hospital, Naval Medical University, and a visiting scholar at the Medical College of Georgia. Dr. Xue holds 11 national patents and has led multiple nationally funded research projects.
JX
Jing Xu
Dr. Jing Xu, M.D., Ph.D., is Associate Professor in the Department of Nephrology at Shanghai Changzheng Hospital. With extensive expertise, she specializes in diagnosing and treating both acute and chronic kidney dysfunction stemming from conditions such as chronic glomerulonephritis, diabetes, and hypertension. Dr. Xu’s research focuses on decoding the mechanisms of chronic kidney fibrosis and persistent inflammation following acute kidney injury, particularly centering on the Hippo pathway and its components. Her contributions have been recognized with several grants from the National Science Foundation and the local medical ministry.
BY
Bo Yang
Bo Yang, MD, PhD, is a nephrologist in the Department of Nephrology at the Naval Medical Center of PLA, Naval Medical University, Shanghai, China, and has served as a visiting scholar at Duke University. His clinical and research interests focus on acute kidney injury, chronic kidney disease, dialysis, renal nutrition, and polycystic kidney disease. Dr. Yang has been actively involved in clinical and translational research in nephrology and has contributed to studies addressing disease mechanisms, nutritional management, and complications of kidney disease.
LJ
Lyu Jiayi
Lyu Jiayi, MD is Associate Chief Physician within the Department of Nephrology, Shanghai Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, China. Dr. Jiayi’s research is focused on pathogenesis, diagnosis, and treatment of autosomal dominant polycystic kidney disease (ADPKD) as well as clinical management of acute and chronic kidney diseases.
LY